Patent · US Active

Method and device for interventricular septal ablation

US12193726B2 · kind B2 · utility

0Cited by
2References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 21, 2022
Grant dateJan 14, 2025
Priority date
Expiry dateJul 13, 2043

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61F2250/0063
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

A method for treating hypertrophic cardiomyopathy (HCM) utilizes an RF ablation electrode needle system that has an RF ablation generator, and an electrode needle. The distal end of the electrode needle is introduced to puncture within myocardium after piercing through epicardium and then advanced along an intramyocardial pathway between endocardia at two lateral sides of the interventricular septum to reach a hypertrophic area of an interventricular septum. The RF ablation generator is then turned on to implement single-point or multi-point ablation on the hypertrophic area of the interventricular septum, and then the RF electrode needle is withdrawn from the patient.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.